SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
23 hedge funds and large institutions have $1.08M invested in Sienna Biopharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$29.3K | |
| 2 | +$4.14K | |
| 3 | +$229 | |
| 4 |
JP Morgan Chase
New York
|
+$15 |
Top Sellers
| 1 | -$2.25M | |
| 2 | -$1.62M | |
| 3 | -$660K | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$515K |
| 5 |
Renaissance Technologies
New York
|
-$510K |